Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Dermatology | Monthly Briefing

Back to Journal Articles

August 2011 Briefing - Dermatology

Last Updated: September 01, 2011.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for August 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Loss of Jobs Means Loss of Health Coverage for Many in U.S.

MONDAY, Aug. 29 (HealthDay News) -- For American adults who lose their health insurance coverage when they lose their jobs, the majority remain uninsured, delay getting needed health care or prescriptions, and report financial difficulties paying medical bills, according to a report published online Aug. 24 by The Commonwealth Fund.

Report

Exclusive Breast-Feeding Doesn't Lower Eczema Risk

MONDAY, Aug. 29 (HealthDay News) -- There is no evidence that exclusive breast-feeding for four or more months provides protection against childhood eczema, according to a study published online Aug. 24 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Complementary Medicine Used More by Health Care Workers

FRIDAY, Aug. 26 (HealthDay News) -- U.S. health care workers, especially health care providers, are more likely to use complementary and alternative medicine (CAM) than the general, employed U.S. population, according to a study published online Aug. 22 in Health Services Research.

Abstract
Full Text (subscription or payment may be required)

Pharmaceutical Ads Often Don't Adhere to U.S. FDA Guidelines

THURSDAY, Aug. 25 (HealthDay News) -- Physician-targeting pharmaceutical advertisements have low rates of adherence to U.S. Food and Drug Administration (FDA) guidelines and provide inadequate information for safe prescribing, according to a study published online Aug. 17 in PLoS One.

Full Text (subscription or payment may be required)

Biologic Therapies for Psoriasis Do Not Up CV Risk

TUESDAY, Aug. 23 (HealthDay News) -- Biologic therapies anti-interleukin (IL)-12 and IL-23 [anti-IL-12/23] and anti-tumor necrosis factor α (TNF-α) in patients with chronic plaque psoriasis (CPP) do not increase the risk of major adverse cardiovascular events (MACEs), according to a meta-analysis published online Aug. 24 in the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

CDC: 2010/2011 Flu Vaccination Coverage Studied

THURSDAY, Aug. 18 (HealthDay News) -- Influenza vaccination coverage among health care personnel (HCP) and pregnant women in the 2010/2011 influenza season was similar to coverage for the 2009/2010 season, according to two reports in the Aug. 19 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Full Text - Health Care Personnel
Full Text - Pregnant Women

High Cumulative Malpractice Risk for All Physicians

THURSDAY, Aug. 18 (HealthDay News) -- Physicians in all specialties have a high cumulative risk of facing a malpractice claim by age 65; although most claims do not lead to indemnity payments, according to a study published in the Aug. 18 issue of the New England Journal of Medicine.

Abstract
Full Text

IL-36-Receptor Antagonist Tied to Pustular Psoriasis

WEDNESDAY, Aug. 17 (HealthDay News) -- Generalized pustular psoriasis is associated with mutated interleukin-36-receptor antagonist (interleukin-36Ra) structure and unregulated production of inflammatory cytokines, according to a study published in the Aug. 18 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

New Drug Approved for Advanced Skin Cancer

WEDNESDAY, Aug. 17 (HealthDay News) -- Zelboraf (vemurafenib) has been approved by the U.S. Food and Drug Administration to treat a certain form of metastatic (spreading) melanoma, or cases that cannot be removed surgically, the agency said Wednesday.

this approval

High Vitamin D Levels Up Nonmelanoma Skin Cancer Risk

WEDNESDAY, Aug. 17 (HealthDay News) -- Higher baseline serum 25-hydroxyvitamin D (25-OHD) levels are significantly and positively associated with an increased risk of nonmelanoma skin cancer (NMSC), according to a study published online Aug. 15 in the Archives of Dermatology.

Abstract
Full Text

New Pressure Device Safe, Effective For Auricular Keloids

WEDNESDAY, Aug. 17 (HealthDay News) -- Overnight use of a new pressure device as an adjuvant therapy for the treatment of auricular keloids is safe and effective, with the potential for prophylaxis of recurrence, according to a study published online Aug. 15 in the Archives of Facial Plastic Surgery.

Abstract
Full Text

Diabetic Dermopathy Tied to Abnormal Skin Blood Flow

WEDNESDAY, Aug. 17 (HealthDay News) -- The pretibial surfaces of the legs of patients with diabetic dermopathy have significantly lower skin blood flow on normal-appearing skin than in control patients, whereas dermopathy lesions have higher blood flow, according to a study published in the September issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Prolonged Tetracycline for Acne Lowers S. aureus Colonization

WEDNESDAY, Aug. 17 (HealthDay News) -- In patients with acne, the prolonged use of tetracycline antibiotics lowers the prevalence of colonization by Staphylococcus aureus (S. aureus) and does not increase resistance to tetracycline antibiotics, according to a study published in the August issue of the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

UVR Exposure From Tanning Beds Ups Cerebral Blood Flow

MONDAY, Aug. 15 (HealthDay News) -- Exposure to ultraviolet radiation (UVR) during use of a tanning bed increases regional cerebral blood flow (rCBF) in the dorsal striatum, anterior insula, and medial orbitofrontal cortex, according to a study published online April 11 in Addiction Biology.

Abstract
Full Text (subscription or payment may be required)

Clindamycin More Effective in Treating Soft Tissue Infections

MONDAY, Aug. 15 (HealthDay News) -- Use of trimethoprim-sulfamethoxazole and β-lactams for treatment of pediatric skin and soft tissue infections (SSTIs) is associated with increased risks of treatment failure and recurrence compared to treatment with clindamycin, according to a study published online Aug. 15 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Vitamin D Deficiency, Gene Polymorphisms Up Food Sensitivity

FRIDAY, Aug. 12 (HealthDay News) -- Vitamin D deficiency (VDD) increases the risk of food sensitization (FS) in children with certain single-nucleotide polymorphisms (SNPs), specifically in IL4, according to a study published online Aug. 5 in Allergy.

Abstract
Full Text (subscription or payment may be required)

CDC: M. haemophilum Infection Possible After Tattooing

THURSDAY, Aug. 11 (HealthDay News) -- Mycobacterium haemophilum (M. haemophilum) infection has been identified in at least one immunocompetent adult with a chronic skin infection after tattooing, according to a study published online Aug. 10 in the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases.

Full Text

Environmental Factors Tied to Psoriatic Arthritis Development

WEDNESDAY, Aug. 10 (HealthDay News) -- Environmental factors, including infections that require antibiotic treatment, injuries, and occupations that involved lifting heavy weights, are significantly associated with the development of psoriatic arthritis (PsA), according to a study published in the August issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Cost of Interacting With Payers Higher in U.S. Than Canada

FRIDAY, Aug. 5 (HealthDay News) -- Physician practices in the United States spend considerably more on interactions with health plans than Canadian practices, according to a study published in the August issue of Health Affairs.

Abstract
Full Text (subscription or payment may be required)

Mechanisms for Allergic Contact Dermatitis Elucidated

FRIDAY, Aug. 5 (HealthDay News) -- Chemical modifications of proteins, and activation of toll-like receptors (TLR2 and TLR4) in the skin are some of the processes involved in activation of innate effector mechanisms and signaling pathways in allergic contact dermatitis (ACD), according to a study published in the September issue of Allergy.

Abstract
Full Text

Cetuximab Effective, Safe for Squamous Cell Skin Carcinoma

TUESDAY, Aug. 2 (HealthDay News) -- In patients with unresectable squamous cell carcinoma of the skin (SCCS), first-line treatment with single-agent cetuximab has an overall disease control rate (DCR) of 69 percent, according to a study published online Aug. 1 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 ScoutNews, LLC. All rights reserved.


Previous: August 2011 Briefing - Cardiology Next: August 2011 Briefing - Diabetes & Endocrinology

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.